Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00280345 · ClinicalTrials.gov registry record · NA
Autoimmune Dysregulation in Pigmentary Glaucoma
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT00280345 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 23 participants.
The verdict
NCT00280345, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Based on these recent observations and findings in this new animal model of pigmentary glaucoma in the DBA/2J mouse, we propose that immune system abnormalities in the anterior chamber may play a possible role in the development of pigmentary glaucoma and possibly primary open-angle glaucoma (POAG) in humans.
Interventions
- PROCEDURE Cataract surgery
- PROCEDURE Trabeculectomy
- PROCEDURE Trabeculectomy and cataract surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00280345
The ClinicalTrials.gov registry entry for NCT00280345 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cataract surgery is the first listed.
NCT00280345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00280345 about?
NCT00280345 is a clinical study titled "Autoimmune Dysregulation in Pigmentary Glaucoma". Based on these recent observations and findings in this new animal model of pigmentary glaucoma in the DBA/2J mouse, we propose that immune system abnormalities in the anterior chamber may play a possible role in the development of pigmentary glaucoma and possibly primary open-angle glaucoma (POAG) ...
What is the current status of trial NCT00280345?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2006-02. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00280345?
The interventions under investigation include: Cataract surgery (PROCEDURE), Trabeculectomy (PROCEDURE), Trabeculectomy and cataract surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00280345?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.